Your Health, We Care
Patients must strictly follow the doctor's instructions regarding the use and dosage of antineoplastic drugs. It is not recommended to change or stop medication without medical advice. Each antineoplastic drug has a specific dosage, method of administration, and schedule that must be strictly adhered to.
Anti-tumor medications can cause various adverse reactions, such as decreased appetite, leukopenia, and alopecia. Patients should diligently monitor their physical responses during treatment and promptly report any adverse effects to their healthcare provider.
Antineoplastic drugs can affect parameters such as blood counts, liver and kidney function. Patients should have regular check-ups to monitor these indicators.
Lumakras
Krazati
Vitrakvi
Lorbrena
Tabrecta
Xpovio
Mobocertinib
Lynparza
Ninlaro
Venclexta
Pemazyre
Gavreto
Retevmo
Cyproterone Acetate
Mekinist
Tafinlar
Cabometyx
Tagrisso
Xalkori
Lysodren
Adlumiz
Alunbrig
Selumetinib
Piqray
Erdafitinib
Lenvima
Tukysa
Rozlytrek
Fotivda
Augtyro
Tepmetko
Jaypirca
Vizimpro
Zelboraf
Zykadia
Alecensa
Gilotrif
Stivarga
Inlyta
Welireg
Truqap
Sutent
Mektovi
Orserdu
Lytgobi
Tazverik
Verzenios
Calquence
Ayvakit
Cotellic
Braftovi
Tarceva
Afinitor
Iressa
Truseltiq
Leclaza
Revlimid
Nerlynx
ZejulaOn November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3652024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：602025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：792025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：892025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：922025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
